Paroxetine Tablet (Extended-Release) Suppliers & Bulk Manufacturers

Available Forms: Tablet (Extended-Release)

Available Strengths: 12.5 mg, 25 mg, 37.5 mg

Reference Brands: US: Paxil®, Pexeva®, Brisdelle®; EU: Seroxat®, ParoMerck®, Paxetin®

Category: Antipsychotropic Drugs

Paroxetine extended-release is a selective serotonin reuptake inhibitor (SSRI) that increases serotonin levels in the brain to improve mood and emotional stability. It is used to treat major depressive disorder, generalized anxiety disorder, social anxiety disorder, and panic disorder, providing sustained symptom relief through its controlled-release formulation for once-daily dosing.

Product Description: Paroxetine extended-release tablets are FDA-approved in the USA for treating major depressive disorder (MDD), panic disorder, social anxiety disorder, and generalized anxiety disorder. As a selective serotonin reuptake inhibitor (SSRI), they require a Boxed Warning for increased suicidality risk in young adults, along with compliance to GMP, labeling regulations, and post-marketing surveillance under FDA’s pharmacovigilance programs. In the EU, while immediate-release formulations are more common, extended-release versions must meet EMA or national agency approval standards, including Risk Management Plans (RMPs) and Periodic Safety Update Reports (PSURs). Explore dossier-ready supplies at Pharmatradz.com.